NCT00727883已完成不适用
Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 190
- 主要终点
- incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs
研究概览
简要总结
Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs
- •Documented reasons for treatment withdrawal
排除标准
- •enrollment in other studies
- •treatment withdraw for other causes than Tam related AEs
结局指标
主要结局
incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs
时间窗: January 2003-December 2004
次要结局
- Types of TAM related AE(January 2003-December 2004)
研究者
相似试验
撤回
不适用
Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRIBreast CancerNCT01297231Memorial Sloan Kettering Cancer Center
已完成
不适用
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 PolymorphismsBreast CancerCYP2D6 PolymorphismNCT01075802Western Sydney Local Health District121
Unknown
不适用
Oocyte Recovery During Tamoxifen Adjuvant TherapyBreast CancerNCT02355600Instituto de Investigacion Sanitaria La Fe20
已完成
4 期
Pharmacology of Adjuvant Hormonotherapy in Breast CancerHormono-depending Adjuvant Breast CancerNCT01127295Institut Claudius Regaud2,000
Unknown
不适用
Decision Aids for Tamoxifen Treatment in Breast Cancer PatientsBreast CancerNCT02488603National Cancer Center, Korea360